Central nervous system multiple myeloma – potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains [PDF]
Denise Lee +8 more
openalex +1 more source
Inhibition of XPO1 is a promising modality in the treatment of MDS, especially when combined with Venetoclax, which activates mitochondria‐mediated apoptosis and could be a potential target for MDS therapy. ABSTRACT Background Myelodysplastic syndromes (MDS) are clonal hematopoietic malignancies that pose a serious health threat.
Xiaohan Liu +8 more
wiley +1 more source
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
M. Mateos +28 more
semanticscholar +1 more source
Incidental discovery of acquired factor X deficiency in a patient with multiple myeloma. [PDF]
Sbibih Y +6 more
europepmc +1 more source
Additional file 1: of Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma
Maria CucĂ ̈ +18 more
openalex +1 more source
Pseudohyperphosphatemia in Multiple Myeloma: A Systematic Review of Case Reports and Case Series
Pseudohyperphosphatemia (PHP) is a clinically significant laboratory artifact in patients with multiple myeloma (MM). It is often caused by paraprotein interference with phosphate assays. This systematic review summarizes reported cases, underlying mechanisms, and diagnostic approaches to distinguish spurious from true hyperphosphatemia.
Mahsa Dabir +3 more
wiley +1 more source
Antitumor activity of thalidomide in refractory multiple myeloma.
S. Singhal +13 more
semanticscholar +1 more source
Sinonasal extramedullary plasmacytoma: A case report of unilateral nasal obstruction with epistaxis. [PDF]
Rguyeg A, Boutahar M, Lachkar A.
europepmc +1 more source
The potential of inhibiting glutamine uptake as a therapeutic target for multiple myeloma [PDF]
Nicola Giuliani +7 more
openalex +1 more source
ABSTRACT Background and Objectives While tranexamic acid (TXA) reduces blood loss in orthopedic surgery, thromboembolic concerns in cancer patients have limited adoption in orthopedic oncology. This study evaluated TXA efficacy and safety in patients undergoing endoprosthetic reconstruction for oncologic indications.
Stephen W. Chenard +10 more
wiley +1 more source

